J. Dell

发表

Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

Walter A. Korfmacher, W. R. Bishop, Jianping Chen, 1999, Cancer Chemotherapy and Pharmacology.

Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.

Chiehying Y Chang, M. Gottardis, R. Attar, 2005, Journal of medicinal chemistry.

Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.

S. Fischer, D. Bol, K. Kiguchi, 2002, Cancer research.

Mice Results in Suppression of Tumor Development Cyclooxygenase-2 Overexpression in the Skin of Transgenic

S. Fischer, D. Bol, K. Kiguchi, 2002 .

Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.

E. Maxwell, J. Catino, L. Nielsen, 1997, Cancer gene therapy.

Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events

G. Grover, J. Fondell, J. Dell, 2011, Molecular and Cellular Endocrinology.

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

L. Nielsen, B. Shi, J. Dell, 1999, Cancer Chemotherapy and Pharmacology.

Adenovirus-mediated p 53 Gene Therapy and Paclitaxel Have Synergistic Efficacy in Models of Human Head and Neck , Ovarian , Prostate , and Breast Cancer

L. Nielsen, J. Dell, P. Lipari, 2005 .

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.

L. Nielsen, G. Hajian, L L Nielsen, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Walter A. Korfmacher, W. R. Bishop, J. Catino, 1998, Cancer research.

Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.

Walter A. Korfmacher, W. R. Bishop, J. Chen, 1998, Journal of medicinal chemistry.

Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.

W. R. Bishop, J. Catino, M. Malkowski, 1997, Journal of medicinal chemistry.

Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.

L. Nielsen, M. Cartwright, J. Dell, 1998, Human gene therapy.